December 06, 2024 18:48 (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Chaos in Parliament after cash recovered from Congress MP Abhishek Singhvi's Rajya Sabha seat | RBI keeps repo rate unchanged at 6.5%, slashes CRR to 4 percent | Allu Arjun booked over woman's death in stampede during Pushpa 2 screening | 'Will appoint new PM in coming days': French President Emmanuel Macron after Michel Barnier's ouster | 'Hope there are no more shocks in future': Devendra Fadnavis after taking oath as Maharashtra CM

After India's warning, UK approves Covishield but says no to CoWIN certificate

New Delhi/IBNS: India's warning has prompted the United Kingdom to approve Serum Institute of India (SII)'s anti-COVID-19 vaccine, Covishield, but questions have been raised over the CoWIN certificate, in what could further escalate the bilateral tension.

Seven EU nations, Switzerland, Iceland clear Covishield amid travel pass row

New Delhi/IBNS: In a big diplomatic win for India, seven European Union (EU) nations along with Switzerland and Iceland have cleared Serum Institute of India (SII)'s anti-COVID-19 vaccine Covishield amid row over travel pass, media reports said.

Hope to resolve soon: SII CEO Adar Poonawalla on Covishield-vaccinated Indians facing EU travel issues

Pune/IBNS: Serum Institute of India (SII) CEO Adar Poonawalla on Monday said he hopes to resolve the issues which Covishield-vaccinated Indians, who are planning to travel to Europe, are facing.

Aggression over Covid vaccines overwhelming, says Adar Poonawalla hinting to start producing in Britain

London: Amid India's catastrophic Covid19 crisis and demand for vaccines, Serum Institute of India (SII) CEO Adar Poonawalla on Saturday said he was under pressure and aggression over vaccines is overwhelming. He also hinted at starting production outside India in a country like Britain.

Serum Insititute chief Adar Poonwalla to get 'Y-category' security cover

New Delhi/IBNS: Pune-based Serum Institute of India's chief Adar Poonawalla will be provided with 'Y-category' security across the country, media reports said.

Opposition targets Modi govt over 'vaccine discrimination' after Serum Institute announces Covishield prices

New Delhi/IBNS: Mounting pressure further on the Centre, several opposition leaders have criticised the Narendra Modi government over the difference in prices at which the Serum Institute of India (SII) has decided to sell its Covid-19 vaccine to the Centre, states and private hospitals.

Vaccine diplomacy: Advantage India as Sri Lanka replaces Chinese vaccine with India-made AstraZenca shots over safety concerns

Colombo/New Delhi/IBNS: In what is being viewed as a big win for India in vaccine diplomacy, Sri Lanka has put on hold Chinese Sinopharm's COVID-19 vaccine and would use India-manufactured Oxford AstraZeneca vaccine to vaccinate 14 million people, media reports said.

NCP chief Sharad Pawar visits to Serum Institute in Pune

Pune/UNI:: NCP chief Sharad Pawar on Saturday visited the city-based Serum Institute of India (SII), where a major fire had broken out two days ago, killing five persons.

Production of Covishield is on schedule, remains unaffected by fire tragedy: Serum Institute CEO Adar Poonawalla

Pune: A day after a massive fire hit vaccine-maker Serum Institute of India's Pune facility, company's CEO Adar Poonawalla on Friday assured the production of Covishield, the vaccine meant to fight against COVID-19, is on schedule and remains unaffected by the tragedy.

Covid-19 vaccination drive: Serum Institute of India CEO Adar Poonawalla gets inoculated

Pune/IBNS: Joining the crores of health workers, Serum Institute of India (SII) CEO Adar Poonwalla got himself inoculated with Covid-19 vaccine made by his own pharmaceutical company.

'Will file Rs. 100 cr defamation suit': Serum Institute after vaccine trial participant claims to fall ill

Pune/IBNS: The Serum Institute of India (SII), which has developed the Oxford vaccine to treat Novel Coronavirus in the country, said it would slap a defamation suit of Rs. 100 crore against an individual who claimed to have fallen ill after taking a dose of Covid-19 vaccine during the trial, media reports said.

Applying for emergency use of Covid-19 vaccine in 2 weeks: Serum Institute

New Delhi/IBNS: The Serum Institute will apply within two weeks for an emergency license to use the coronavirus vaccine being developed by the University of Oxford and pharma giant AstraZeneca, the Indian vaccine maker's chief Adar Poonawalla said on Saturday after a meeting with Prime Minister Narendra Modi.

Had a good interaction with team: Indian PM Narendra Modi tweets after visiting Serum Institute of India

Pune: Indian PM Narendra Modi on Saturday visited Pune's Serum Institute of India, which is working on the coronavirus vaccine, and interacted with the team at the Institute.

Narendra Modi to visit Pune’s Serum Institute of India on Saturday

Pune/UNI: Prime Minister Narendra Modi will visit the Serum Institute of India (SII) in Pune on Saturday to ‘understand the process of vaccine production and distribution'.